Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

6.79

-0.45 (-6.22%)

At close: Aug 14, 2026, 4:00 PM EDT

6.82

+0.03 (0.44%)

After-hours: Aug 14, 2026, 7:59 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cell Engineering Revenue	95.01M	132.75M	173.97M
Biosecurity Service Revenue	24.53M	37.41M	53.07M
Total Biosecurity Revenue	24.53M	37.41M	53.07M
Revenue (Other)	-47.30M	-	-
Revenue (Total)	72.23M	170.16M	227.04M

EBIT

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cell Engineering Operating Income	-183.93M	-95.53M	-218.57M
Biosecurity Operating Income	-29.67M	-18.93M	-30.62M
Corporate Operating Income	-	-200.82M	-310.57M
Operating Income (Other)	-77.09M	-	-
Operating Income (Total)	-290.69M	-315.28M	-559.76M

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.